| scholarly article | Q13442814 |
| P50 | author | Soon Pal Suh | Q58859974 |
| Sun Hoe Koo | Q59692014 | ||
| P2093 | author name string | Dong Wook Ryang | |
| Jong Hee Shin | |||
| Min Ji Choi | |||
| Myung Geun Shin | |||
| Soo Hyun Kim | |||
| Hye Soo Lee | |||
| Min Seok Heo | |||
| Won Gil Lee | |||
| Yeon Joon Park | |||
| P2860 | cites work | Antifungal susceptibility of the aspergillus species by Etest and CLSI reference methods. | Q50934170 |
| In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. | Q51193344 | ||
| Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping | Q31065559 | ||
| Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds | Q33960284 | ||
| Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus | Q34231728 | ||
| Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience | Q34455699 | ||
| Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait | Q34621506 | ||
| Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods | Q36022880 | ||
| Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network | Q37374801 | ||
| Aspergillus species intrinsically resistant to antifungal agents. | Q37775969 | ||
| Update on antifungal resistance in Aspergillus and Candida. | Q38174185 | ||
| Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). | Q38726054 | ||
| Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species | Q39628247 | ||
| In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods | Q42076268 | ||
| In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing | Q42111761 | ||
| Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis. | Q42257843 | ||
| Aspergillus species identification in the clinical setting. | Q43087816 | ||
| Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | Q43521723 | ||
| Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole | Q43815790 | ||
| In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies. | Q44146174 | ||
| EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole | Q45152541 | ||
| Current section and species complex concepts in Aspergillus: recommendations for routine daily practice | Q45249125 | ||
| Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry | Q45374123 | ||
| Aspergillus niger contains the cryptic phylogenetic species A. awamori. | Q46960245 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amphotericin B | Q412223 |
| P304 | page(s) | 602-610 | |
| P577 | publication date | 2015-11-01 | |
| P1433 | published in | Annals of laboratory medicine | Q26853883 |
| P1476 | title | Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea | |
| P478 | volume | 35 |
| Q94503361 | Antifungal Susceptibility Tests and the cyp51 Mutant Strains among Clinical Aspergillus fumigatus Isolates from Korean Multicenters |
| Q46290816 | Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea. |
| Q42708333 | Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates. |
| Q58609294 | Emergence of Voriconazole-resistant Isolates in Korean Hospitals: Microsatellite Typing and Resistance Mechanism Analysis |
| Q91831439 | MALDI-TOF MS for the rapid identification and drug susceptibility testing of filamentous fungi |
| Q50028303 | Species identification and in vitro-antifungal susceptibility of Aspergillus terreus species complex clinical isolates: a French multicentre study |
| Q57214260 | TR34/L98H Mutation in CYP51A Gene in Aspergillus fumigatus Clinical Isolates During Posaconazole Prophylaxis: First Case in Korea |
Search more.